J Reconstr Microsurg 2008; 24(5): 351-359
DOI: 10.1055/s-2008-1080538
© Thieme Medical Publishers

Protective Effect of a Nuclear Factor-Kappa B Inhibitor on Ischemia-Reperfusion Injury in a Rat Epigastric Flap Model

Xiaowei Wu1 , Mosheng Yu1 , Ailin Li1
  • 1Renmin Hospital of Wuhan University, Wuhan City, People's Republic of China
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
02. Juli 2008 (online)

Preview

ABSTRACT

We examined whether nuclear factor-kappa B (NF-κB) activation was involved in the ischemia-reperfusion (I/R) injury in a rat skin flap model and whether administration of pyrrolidine dithiocarbamate (PDTC), a NF-κB inhibitor, could improve flap viability. Eighty-four Sprague-Dawley rats were divided into control group (n = 28), I/R group (n = 28), and PDTC-treated group (n = 28). An abdominal skin flap (4 × 5 cm) was elevated and subjected to 10 hours of ischemia in both the I/R group and the PDTC-treated group. A bolus of PDTC (300 mg/kg) was infused 5 minutes before reperfusion, followed by a second dose during the first 30 minutes of reperfusion in the PDTC-treated group. Flap tissues were assessed by electrophoretic mobility shift assay at 1, 2, 3, and 6 hours of reperfusion, and myeloperoxidase activity and neutrophil infiltration were assessed at 12 hours of reperfusion. The viability of flaps was assessed 7 days postoperatively. NF-κB was activated after reperfusion in the I/R group and displayed peak activity at 1 and 3 hours of reperfusion. In the PDTC-treated group, NF-κB activity was significantly reduced at 1, 2, and 6 hours of reperfusion. Myeloperoxidase activity was significantly decreased, and little neutrophil infiltration could be observed. In the PDTC-treated group, the survival of flaps was 86.88 ± 13.63%, which was significantly greater than the I/R group, in which only 19.20 ± 7.52% of the flap survived. NF-κB is activated during reperfusion in a rat skin flap I/R model. Administration of PDTC can significantly improve flap survival by regulating the early activation of NF-κB and suppressing neutrophil infiltration within the flap.

REFERENCES

Xiaowei WuPh.D. 

Associate Professor of Plastic and Reconstructive Surgery, Renmin Hospital of Wuhan University

Ziyang Road 99, Wuhan City, People's Republic of China